IPERIONX LTD - ADR (IPX) Stock Fundamental Analysis

NASDAQ:IPX • US44916E1001

45.87 USD
-1.51 (-3.19%)
Last: Feb 26, 2026, 12:48 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

IPX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 156 industry peers in the Metals & Mining industry. The financial health of IPX is average, but there are quite some concerns on its profitability. While showing a medium growth rate, IPX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • IPX had negative earnings in the past year.
  • In the past year IPX has reported a negative cash flow from operations.
  • IPX had negative earnings in each of the past 5 years.
  • In the past 5 years IPX always reported negative operating cash flow.
IPX Yearly Net Income VS EBIT VS OCF VS FCFIPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

  • The Return On Assets of IPX (-18.86%) is worse than 75.00% of its industry peers.
  • With a Return On Equity value of -20.70%, IPX is not doing good in the industry: 70.51% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -18.86%
ROE -20.7%
ROIC N/A
ROA(3y)-111.03%
ROA(5y)-168.25%
ROE(3y)-139.15%
ROE(5y)-240.98%
ROIC(3y)N/A
ROIC(5y)N/A
IPX Yearly ROA, ROE, ROICIPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600

1.3 Margins

  • IPX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IPX Yearly Profit, Operating, Gross MarginsIPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -50K -100K -150K -200K -250K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • IPX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • IPX has more shares outstanding than it did 1 year ago.
  • IPX has more shares outstanding than it did 5 years ago.
  • IPX has a worse debt/assets ratio than last year.
IPX Yearly Shares OutstandingIPX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
IPX Yearly Total Debt VS Total AssetsIPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • IPX has an Altman-Z score of 92.07. This indicates that IPX is financially healthy and has little risk of bankruptcy at the moment.
  • IPX's Altman-Z score of 92.07 is amongst the best of the industry. IPX outperforms 91.67% of its industry peers.
  • IPX has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • IPX has a Debt to Equity ratio of 0.03. This is in the better half of the industry: IPX outperforms 70.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 92.07
ROIC/WACCN/A
WACC11.18%
IPX Yearly LT Debt VS Equity VS FCFIPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 11.80 indicates that IPX has no problem at all paying its short term obligations.
  • IPX has a Current ratio of 11.80. This is amongst the best in the industry. IPX outperforms 91.03% of its industry peers.
  • IPX has a Quick Ratio of 11.80. This indicates that IPX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 11.80, IPX belongs to the top of the industry, outperforming 91.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.8
Quick Ratio 11.8
IPX Yearly Current Assets VS Current LiabilitesIPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • IPX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.37%.
  • Looking at the last year, IPX shows a quite strong growth in Revenue. The Revenue has grown by 10.41% in the last year.
  • The Revenue has been growing by 78.65% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)3.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)10.41%
Revenue growth 3Y374.83%
Revenue growth 5Y78.65%
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, IPX will show a very strong growth in Earnings Per Share. The EPS will grow by 60.53% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-24.18%
EPS Next 2Y21.54%
EPS Next 3Y31.76%
EPS Next 5Y60.53%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPX Yearly Revenue VS EstimatesIPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M
IPX Yearly EPS VS EstimatesIPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • IPX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year IPX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPX Price Earnings VS Forward Price EarningsIPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 -100 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IPX Per share dataIPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

  • IPX's earnings are expected to grow with 31.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.54%
EPS Next 3Y31.76%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • IPX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IPERIONX LTD - ADR

NASDAQ:IPX (2/26/2026, 12:48:03 PM)

45.87

-1.51 (-3.19%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)09-29
Earnings (Next)03-17
Inst Owners40.83%
Inst Owner Change110.33%
Ins Owners14.08%
Ins Owner ChangeN/A
Market Cap1.54B
Revenue(TTM)546.00K
Net Income(TTM)-21.84M
Analysts80
Price Target51.44 (12.14%)
Short Float %2.18%
Short Ratio3.58
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)41.06%
PT rev (3m)29.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-22.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2825.48
P/FCF N/A
P/OCF N/A
P/B 14.62
P/tB 16.88
EV/EBITDA N/A
EPS(TTM)-0.81
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)-0.67
OCFYN/A
SpS0.02
BVpS3.14
TBVpS2.72
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -18.86%
ROE -20.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-111.03%
ROA(5y)-168.25%
ROE(3y)-139.15%
ROE(5y)-240.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 2601.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.8
Quick Ratio 11.8
Altman-Z 92.07
F-Score3
WACC11.18%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)909.1%
Cap/Sales(5y)2901.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y-24.18%
EPS Next 2Y21.54%
EPS Next 3Y31.76%
EPS Next 5Y60.53%
Revenue 1Y (TTM)10.41%
Revenue growth 3Y374.83%
Revenue growth 5Y78.65%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.72%
EBIT Next 3Y42.97%
EBIT Next 5Y66.14%
FCF growth 1Y-106.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.9%
OCF growth 3YN/A
OCF growth 5YN/A

IPERIONX LTD - ADR / IPX FAQ

What is the ChartMill fundamental rating of IPERIONX LTD - ADR (IPX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to IPX.


What is the valuation status of IPERIONX LTD - ADR (IPX) stock?

ChartMill assigns a valuation rating of 1 / 10 to IPERIONX LTD - ADR (IPX). This can be considered as Overvalued.


Can you provide the profitability details for IPERIONX LTD - ADR?

IPERIONX LTD - ADR (IPX) has a profitability rating of 0 / 10.


What is the financial health of IPERIONX LTD - ADR (IPX) stock?

The financial health rating of IPERIONX LTD - ADR (IPX) is 6 / 10.